---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047742"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T17:35:07.928564+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals stockholders approve 2.26M share increase to equity plan

## Summary
- Stockholders re-elected all seven director nominees: Glass, Eagle, Schreiber, Silverman, Uzonwanne, White, Friscia.
- Equity plan share reserve increased by 2,259,060 to 2,500,000 total, approved with 2.92M for and 116K against.
- Stephano Slack LLC ratified as independent auditor for FY 2024 with 3.74M votes for.
- Adjournment proposal approved with 3.42M votes for to permit further solicitation if needed.
- Voting results final; no other matters considered at the annual meeting.

## SEC filing metadata
- accession: 0001493152-24-047742
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224047742/0001493152-24-047742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224047742/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047742
- JSON: https://secwatch.observer/filing/0001493152-24-047742.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047742.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.